| Similar Articles |
|---|
 |
Nutra Solutions
June 1, 2005 |
Pomegranate Extract Consistent with previous studies, new in vitro research indicates a pomegranate extract from Geni Herbs displays five times greater antioxidant behavior than vitamin E or ellagic acid.   |
American Family Physician
December 15, 2000
Alan J. Garber |
Attenuating Cardiovascular Risk Factors in Patients with Type 2 Diabetes All cardiovascular risk factors except smoking are more prevalent in patients with type 2 diabetes. In addition to exercise, weight control, aspirin therapy and blood pressure control, therapy to modify lipid profiles is usually necessary... |
American Family Physician
January 15, 2001 |
Goals for Lowering Your Cholesterol Why is it important to have a normal cholesterol level?... What does the term "total cholesterol" mean?... Why is LDL called the "bad" cholesterol?... What are normal cholesterol levels?... How can I reduce my LDL and total cholesterol levels?... etc. |
American Family Physician
March 1, 2002
Richard S. Safeer |
Cholesterol Treatment Guidelines Update In addition to modifying current strategies of risk assessment, the new guidelines stress the importance of an aggressive therapeutic approach in the management of hypercholesterolemia... |
Prepared Foods
August 1, 2005
Kerry Hughes |
Fruits from the Tree of Life A new proprietary blend of pomegranate ellagitannins, gallotannins and anthocyanins, is now available on the market for use in dietary supplements and functional foods. It is available in powder, granular and tea cut forms. |
Chemistry World
January 19, 2009
Manisha Lalloo |
Synthetic HDL could boost body's 'good cholesterol' US scientists say gold nanoparticle based therapies could be used to help boost levels of good cholesterol in our bodies. |
American Family Physician
January 15, 2002
Lori J. Mosca |
Optimal Management of Cholesterol Levels and the Prevention of Coronary Heart Disease in Women Elevated levels of low-density lipoprotein cholesterol and triglycerides and low levels of high-density lipoprotein cholesterol are significant risk factors for coronary heart disease. Abundant data show inadequate utilization of lipid-lowering therapy in women... |
Chemistry World
August 23, 2007
Richard Van Noorden |
How Good Cholesterol Turns Bad Chemists have peered into the depths of HDL, which protects against heart disease, to explain why it can become harmful. The research may also suggest an explanation for the near-billion-dollar failure of Pfizer's blockbuster heart drug, torcetrapib, in recent clinical trials. |
American Family Physician
January 15, 2001
Michael A. Crouch |
Effective Use of Statins to Prevent Coronary Heart Disease Primary and secondary prevention trials have shown that use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (also known as statins) to lower an elevated low-density lipoprotein level can substantially reduce coronary events and death from coronary heart disease... |
Chemistry World
March 8, 2012
Jennifer Newton |
Butter substitute reduces blood pressure and cholesterol Scientists from Finland have shown that a spread containing milk peptides and plant sterols could lower systolic blood pressure and LDL (low density lipoprotein) cholesterol levels. |
BusinessWeek
December 13, 2004
Kate Murphy |
Cholesterol: The Bigger the Better Many doctors are convinced that getting a more thorough cholesterol test, one that identifies the types of LDL particles, can improve treatment and save lives. |
Health
January 2008
Jessica Snyder Sachs |
What You Must Know About Your Cholesterol Many of us are in the danger zone, and we don't realize it. What can we start to do right now to change that? |
BusinessWeek
April 19, 2004
Catherine Arnst |
Cholesterol: How Low Should It Be? New studies say as low as possible, but drugs aren't for everybody |
Chemistry World
May 28, 2012
Sarah Houlton |
HDL drug class struggling after latest flop The failure of dalcetrapib, a drug from Roche designed to raise HDL, or 'good', cholesterol, has turned the spotlight again on such drugs. |
The Motley Fool
December 23, 2003
Arash Mostaghimi |
The Cholesterol Wars Who will win the fight to save your arteries? Fortunately for our corpulent country, pharmaceutical companies want to unclog our arteries -- and lighten our wallets. But which pharma stock will add to most girth to a portfolio? |
